New
Data-Driven Drug Development in Vitiligo
In an interview with Dermatology Times, Stefan Weiss, MD from OM1, a data analytics company, highlighted how leveraging large-scale data analytics can enhance dermatological care, especially for conditions like vitiligo. By creating detailed datasets, OM1 aims to personalize treatment, ensuring patients receive the most effective drugs for their specific conditions. This method promises improved outcomes by analyzing diverse patient responses.
Their study, presented at the ISPOR Annual Conference in Boston, utilized the OM1 Dermatology Network to examine vitiligo's impact, exploring demographics, mental health, and treatment trends in 26,016 patients, based on healthcare claims and patient records from 2013 to 2022. Findings reveal a majority female demographic, diverse racial composition, and common use of treatments like corticosteroids and UVB phototherapy.
Download poster "Patient Characteristics and Social Determinants of Health in a Large Real-World Cohort of Vitiligo Patients in the U.S." in full size here below.
FAQOther Questions
- Who is prone to vitiligo?
Vitiligo can affect anyone, regardless of gender, age, or race. Vitiligo prevalence is between 0.76% and 1.11% of the U.S. population, including around 40% of those with the con...
- How Vitiligo Changes with Age?
Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...
- Белые пятна на теле? Витилиго?
Гид по Витилиго — ваш компас в лабиринте загадочной болезни и непростых решений. Здесь всё по-честному, по делу и на понятном языке. Вы найдёте здесь: Объяснения, что происходи...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.